| NCT ID | NCT06418048 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Raffaele |
| Condition | Bloodstream Infections |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2044-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2024-02-01 with a primary completion date of 2044-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective observational study designed to describe the clinical, laboratory, imaging, microbiological characteristics and treatment of specific infectious diseases, with the addition of a dedicated biobank.
Eligibility Criteria
Inclusion Criteria: * Patients with clinically suspected or microbiologically documented infectious diseases (bacterial, viral, fungal or parasitic); * At least 18 years of age or older; * Able to provide informed consent; * Participants who are unable to understand the study protocol or are unable to give informed consent, but have a legal representative Exclusion Criteria: \- Participants who are unable to understand the study protocol or are unable to give informed consent, and have no legal representative.
Contact & Investigator
Marco Ripa, MD
PRINCIPAL INVESTIGATOR
IRCCS San Raffaele Scientific Institute
Frequently Asked Questions
Who can join the NCT06418048 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bloodstream Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06418048 currently recruiting?
Yes, NCT06418048 is actively recruiting participants. Contact the research team at carini.elisabetta@hsr.it for enrollment information.
Where is the NCT06418048 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06418048 clinical trial?
NCT06418048 is sponsored by IRCCS San Raffaele. The principal investigator is Marco Ripa, MD at IRCCS San Raffaele Scientific Institute. The trial plans to enroll 10,000 participants.